BRII-196/BRII-198
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BRII-196/BRII-198, covering 2024-02-05 to 2024-02-05. Get the full timeline:
Most recent: Clinical Trial Update: BRII-196/BRII-198 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial) [Phase 3]